Baltimore R S, Mitchell M
J Infect Dis. 1980 Feb;141(2):238-47. doi: 10.1093/infdis/141.2.238.
Mucoid strains of Pseudomonas aeruginosa, isolated from patients with cystic fibrosis, were studied for the prevalence of each of the seven Fisher immunotype antigens and were compared with their nonmucoid transformants, obtained by repeated subculturing, for susceptibility to opsonic antibody. Of the 30 strains tested--one from each of 30 patients--16 were typable and were tested in the opsonophagocytic assay with use of immunotype-specific rabbit antiserum; eight had significant opsonization by complement without antiserum. Of the eight strains requiring antiserum, seven strains required a higher minimum concentration of antiserum for a 1.0 log10 reduction of viable P. aeruginosa than the paired nonmucoid derivative. These end-point titers were significantly greater for nonmucoid Pseudomonas (P = 0.0007). A mucoid strain not requiring antibody for opsonization was shown to use primarily the alternative complement pathway. These results are consistent with the hypothesis that the immunodeterminant for opsonic antibody in nonmucoid strains is blocked in the mucoid strain.
对从囊性纤维化患者中分离出的铜绿假单胞菌黏液样菌株进行了研究,以确定七种费舍尔免疫型抗原各自的流行情况,并将其与通过反复传代培养获得的非黏液样转化体进行比较,以检测它们对调理素抗体的敏感性。在测试的30株菌株中(来自30名患者,每人一株),16株可分型,并使用免疫型特异性兔抗血清在调理吞噬试验中进行检测;8株在没有抗血清的情况下通过补体进行了显著的调理作用。在这8株需要抗血清的菌株中,7株菌株在使铜绿假单胞菌活菌数减少1.0 log10时所需的抗血清最低浓度高于配对的非黏液样衍生物。非黏液样铜绿假单胞菌的这些终点滴度显著更高(P = 0.0007)。一株不需要抗体进行调理作用的黏液样菌株被证明主要使用替代补体途径。这些结果与非黏液样菌株中调理素抗体的免疫决定簇在黏液样菌株中被阻断这一假设一致。